🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Navigation Intervention for Adolescent and Young Adult Cancer Survivors

RecruitingNAAges 21 Years - 45 YearsAllKaiser Permanente
NCT07406087 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

The investigators propose to: 1) Adapt an evidence-based cancer-focused patient navigation (PN) program for the Adolescent and Young Adult (AYA) cancer survivor population; and 2) Plan and conduct an effectiveness-implementation trial of this program within Kaiser Permanente Southern California (KPSC). PLEASE NOTE: This study is awarded in two phases. The UG3 phase has been awarded for the first two years; upon successful completion of this phase by meeting pre-defined milestones, the National Cancer Institute (NCI) will provide funding for the second phase of the study (Years 3-6), which will allow our team to conduct a trial to determine the effectiveness of the implementation of the adapted PN program for the AYA cancer survivor population. This application is focused on the initial UG3 phase and will update the protocol for the UH3 trial upon successful completion of the UG3 mileston

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * Received diagnosis of local or regional breast, ovarian, cervical, testicular, colon/rectal, melanoma, endometrial, sarcoma, or thyroid cancer between the ages of 15-39 years ("index cancer") * Current age 21-45 years * Diagnosed and treated for index cancer within Kaiser Permanente Southern California adult medical oncology and/or surgery * Current Kaiser Permanente insurance coverage Exclusion Criteria: * Patients with a history of or current diagnosis of leukemia or lymphoma * Patients with metastatic disease at diagnosis
💊

What it tests

  • Adapted patient navigation program targeting adolescent and young adult cancer survivors
📍

Where

1 site
KP Southern California - Department of Research & Evaluation
Pasadena, United States
🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy